Vimarsana
Biggest News Aggregation in the World

Page 3 - Greg Canter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Canter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Canter Today - Breaking & Trending Today

FDA panel backs Amylyx's much-debated ALS drug - Vimarsana News

FDA panel backs Amylyx's much-debated ALS drug

In a remarkable turnaround, a panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease. Patients and their families have rallied behind Amylyx's drug, urging approval.

Source: fox5ny.com
ALS drug gets backing by FDA panel after rare 2nd review - Vimarsana News

ALS drug gets backing by FDA panel after rare 2nd review

Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.

Source: king5.com
FDA panel backs much-debated ALS drug in rare, 2nd review - Vimarsana News

FDA panel backs much-debated ALS drug in rare, 2nd review

WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend...

FDA panel backs much-debated ALS drug in rare turnaround - Vimarsana News

FDA panel backs much-debated ALS drug in rare turnaround

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.

Source: pbs.org
ALS Drug Gets Rare Second Review at High-Stakes FDA Meeting - Vimarsana News

ALS Drug Gets Rare Second Review at High-Stakes FDA Meeting

A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to...